Catechins containing a galloyl moiety as potential anti-HIV-1 compounds

被引:22
|
作者
Zhao, Yali [1 ]
Jiang, Fan [1 ]
Liu, Ping [1 ]
Chen, Wei [1 ]
Yi, Kejia [2 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China
[2] Beijing Sci Technol & Management Coll, Beijing, Peoples R China
关键词
GREEN TEA CATECHINS; SEMEN-MEDIATED ENHANCEMENT; EPIGALLOCATECHIN-GALLATE; HIV-1; PROTEASE; REVERSE-TRANSCRIPTASE; CD4; POLYPHENOL; BINDING; REPLICATION; METABOLISM;
D O I
10.1016/j.drudis.2012.02.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Catechins containing galloyl moieties are important natural antioxidant compounds. In this paper, we review the multiple mechanisms whereby catechins containing a galloyl moiety can target key proteins to inhibit sexual transmission of HIV-1, as well as HIV-1 fusion, HIV-1 reverse transcriptase, HIV-1 integrase and HIV-1 protease. Furthermore, catechins with a galloyl moiety can mediate host cell factors such as nitric oxide synthase, nuclear factor-kappa B and casein kinase II to inhibit HIV-1 infection. The most significant inhibitory effect is blocking gp120 binding to isolated human CD4(+) T cells. The multiple mechanisms underlying the anti-HIV activity of galloyl-containing catechins predict that these catechins could be used as alternative therapies in the treatment of HIV infection.
引用
收藏
页码:630 / 635
页数:6
相关论文
共 50 条
  • [31] Preclinical studies of alkylureas as anti-HIV-1 contraceptive
    Rubinstein, A
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (29) : 3769 - 3778
  • [32] Molecular bases for the anti-HIV-1 effect of NO - Commentary
    Persichini, T
    Ascenzi, P
    Colizzi, V
    Fraziano, M
    Venturini, G
    Colasanti, M
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1999, 4 (04) : 365 - 368
  • [33] Specificities of broadly neutralizing anti-HIV-1 sera
    Binley, James
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (05) : 364 - 372
  • [34] In vitro Anti-HIV-1 Activity of the Recombinant HIV-1 TAT Protein Along With Tenofovir Drug
    Yadavar-Nikravesh, Maryam-Sadat
    Milani, Alireza
    Vahabpour, Rouhollah
    Khoobi, Mehdi
    Bakhshandeh, Haleh
    Bolhassani, Azam
    CURRENT HIV RESEARCH, 2021, 19 (02) : 138 - 146
  • [35] Insights into the Mechanism of Inhibition of CXCR4: Identification of Piperidinylethanamine Analogs as Anti-HIV-1 Inhibitors
    Das, Debananda
    Maeda, Kenji
    Hayashi, Yasuhiro
    Gavande, Navnath
    Desai, Darshan V.
    Chang, Simon B.
    Ghosh, Arun K.
    Mitsuya, Hiroaki
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 1895 - 1904
  • [36] Molecular dynamics simulation study of gold nanosheet as drug delivery vehicles for anti-HIV-1 aptamers
    Ajamgard, Marzieh
    Sardroodi, Jaber Jahanbin
    Ebrahimzadeh, Alireza Rastkar
    Kamelabad, Mahrokh Rezaei
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2021, 95
  • [37] The topoisomerase II β-kinase associated with HIV-1 is a potential target for pyridine-bischalcones' anti-HIV-1 activity
    Kammari, Kurumurthy
    Devaraya, Kiran
    Swain, Sarita
    Kondapi, Anand K.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259
  • [38] Aqueous Extracts of Thai Medicinal Plants Possess anti-HIV-1 Activity
    Panvilai, Sathit
    Napaswad, Chanita
    Limthongkul, Jitra
    Akkarawongsapat, Radeekorn
    JOURNAL OF HERBS SPICES AND MEDICINAL PLANTS, 2021, 27 (01) : 1 - 10
  • [39] Anti-HIV-1 activity of the Iboga alkaloid congener 18-methoxycoronaridine
    Silva, EM
    Cirne-Santos, CC
    Frugulhetti, ICPP
    Galvao-Castro, B
    Saraiva, EMB
    Kuehne, ME
    Bou-Habib, DC
    PLANTA MEDICA, 2004, 70 (09) : 808 - 812
  • [40] Molecular Docking, Synthesis and anti-HIV-1 Protease Activity of Novel Chalcones
    Turkovic, Nemanja
    Ivkovic, Branka
    Kotur-Stevuljevic, Jelena
    Tasic, Milica
    Markovic, Bojan
    Vujic, Zorica
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (08) : 802 - 814